Lone Oak Acquisition (AXPLF) 0.1800 $AXPLF Arabella

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lone Oak Acquisition (AXPLF) 0.1800 $AXPLF

Arabella Exploration Announces Termination of Portion of Property Sale Deal
Marketwired - Wed Sep 09, 7:22AM CDT
Arabella Exploration, Inc. (OTC PINK: AXPLF) ("Arabella" or the "Company", an oil and gas E&P company focused on the Permian Basin, today announced that the third party buyer ("Buyer" in the Purchase and Sale Agreement ("PSA" between the Company and the Buyer notified the Company that it was terminating the PSA. Pursuant to the PSA, the Buyer had agreed to provide the $15 million cash portion of the previously announced two part sale of Arabella's Locker State, Graham, Woods, Jackson and Emily Bell prospects. McCabe Petroleum Corporation ("McCabe" remains willing to complete its deal as previously announced if a suitable replacement for the Buyer's transaction can be identified.

Arabella Exploration to Present at Upcoming Investor Conferences
Marketwired - Tue Jan 13, 7:03AM CST
Arabella Exploration, Inc. (OTCQB: AXPLF) ("Arabella" or the "Company", an oil and gas E&P company focused on the Southern Delaware portion of the Permian Basin, today announced that management will present at the following investor conferences in February.

Arabella Exploration Increases Ownership in Producing Properties
Marketwired - Mon Nov 24, 7:04AM CST
Arabella Exploration, Inc. (OTCQB: AXPLF) ("Arabella" or the "Company", an oil and gas E&P company focused on the Southern Delaware portion of the Permian Basin, today announced that it has acquired additional working interests in its properties from existing working interest holders. Over a series of five separate transactions, the Company acquired approximately 420 net acres and approximately 350,000 barrels of oil equivalent in proved reserves. These reserves are worth in excess of $6.0 million of proved PV10, including approximately $3.5 million of proved developed producing PV10. Across the five transactions, the Company will pay, in the aggregate, approximately $2.2 million and issue 112,250 of its ordinary shares. The Company will be entitled to production and revenue from the acquired working interests beginning from the effective date of November 1, 2014.

Arabella Exploration Announces Participation in Upcoming Investor Conference
Marketwired - Fri Nov 07, 7:03AM CST
Arabella Exploration, Inc. (OTCQB: AXPLF) ("Arabella" or the "Company" an oil & gas E&P company focused on the Southern Delaware portion of the Permian Basin, today announced that management will present that the following upcoming investor conference.

Arabella Exploration Backs Into Additional Acreage
Marketwired - Fri Oct 24, 7:02AM CDT
Arabella Exploration, Inc. (OTCQB: AXPLF) ("Arabella" or the "Company", an oil and gas E&P company focused on the Southern Delaware portion of the Permian Basin, today announced that it has backed into ownership on additional acreage in Pecos and Reeves County in the Southern Delaware Basin. Arabella has owned a reversionary interest in certain acres controlled by Brigham Resources Operating, LLC ("Brigham". Once Arabella's portion of the expenses to date of drilling and leasehold costs were paid, the interests reverted into standard non-operated, working interests in these wells and properties.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading